HealthQuill Articles by: HealthQuill
The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization, has released 70,000 doses of its experimental Ervebo vaccine to the Democratic Republic of the Congo to assess its effectiveness in combating the Bundibugyo Ebola virus disease.
Drugs Health Research

ICG ships vaccines to Congo to test feasibility in Bundibugyo Ebola

HQ Team August 21, 2026: The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization,

Read More
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.
Pharma

Moderna, Merck’s personalised mRNA vaccine clears Phase 3 in melanoma

HQ Team August 20, 2026: Moderna’s stock more than doubled, surging as much as 177% intraday to $174.38 on Aug. 19, 2026, after

Read More
flight attendants
Health

Aircrew face highest radiation-related cancer risk among all US jobs: Study

HQ Team August 20, 2026: Nearly 7% of deaths among U.S. flight attendants and pilots are linked to radiation-related cancers — the highest

Read More
In conflict-ridden Gaza, just 3% of cropland remains usable as Israeli troops pound the region with air strikes and shelling, limiting access to agricultural land and putting pressure on food security, according to the United Nations' FAO.
Climate Health Research

Cropland usage plummets in war-torn Gaza Strip, 3% usable: FAO

HQ Team August 19, 2026: In conflict-ridden Gaza, just 3% of cropland remains usable to grow food as Israeli troops pound the region

Read More
An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo at an “unprecedented speed” until every transmission chain is found and broken, Dr Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, said.
Drugs Health Pharma

World still ‘playing catch-up’ with Ebola virus epidemic in Congo: WHO chief

HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo

Read More
Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine that may induce an immune response to malaria.
Health

Dundee Lab’s drug shows promise as a single-dose cure for malaria disease

HQ Team August 18, 2026: A malaria drug candidate developed by a University of Dundee lab has cleared an early human trial, raising

Read More
Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health Organization.
Health

Billions lie unutilised as budgeting body dithers over allocation

HQ Team August 18, 2026: The Office of Management and Budget (OMB, the White House office that decides when and how appropriated federal

Read More
AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination therapy failed to outperform standard treatments for advanced non-small cell lung cancer.
Drugs Health Pharma

AstraZeneca ends late-stage trial of drug to treat non-small cell cancer

HQ Team August 17, 2026: AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination

Read More
An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325 people, becoming the deadliest in the central African country of the Democratic Republic of Congo.
Drugs Health Medical

Ebola virus becomes deadliest outbreak in Congo, still ‘moving fast’

HQ Team August 17, 2026: An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325

Read More
Novo Nordisk A/S’s data from a clinical trial of a weight-loss medicine, treating overweight and obese adult participants, showed patients lost about 23% of their body weight compared to a dummy group’s 2-3%.
Health

GLP-1 drugs may stop early-stage cancers from spreading

HQ Team July 28, 2026: People taking GLP-1 drugs (glucagon-like peptide-1 receptor agonists, the same class as Ozempic and Wegovy) for diabetes alongside

Read More